Ignite Creation Date:
2024-05-06 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05361161
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-05-24
First Post:
2022-04-29
Brief Title:
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer GC
Sponsor:
Gang Wu
Organization:
The First Affiliated Hospital of Zhengzhou University
Study Overview
Official Title:
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer GC
Status:
NOT_YET_RECRUITING
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective open-labelled study to evaluate the efficacy and safety of sequential transarterial chemoembolization with lipiodol and neoadjuvant chemotherapy in the treatment of Initial unresectable gastric cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None